CK Life Sciences Int'l. (Holdings) Management
Management criteria checks 2/4
CK Life Sciences Int'l. (Holdings)'s CEO is Lance Richard Yuen, appointed in Sep 2024, has a tenure of less than a year. total yearly compensation is HK$6.88M, comprised of 47.1% salary and 52.9% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth HK$2.14M. The average tenure of the management team and the board of directors is 14.7 years and 6.5 years respectively.
Key information
Lance Richard Yuen
Chief executive officer
HK$6.9m
Total compensation
| CEO salary percentage | 47.1% |
| CEO tenure | less than a year |
| CEO ownership | 0.02% |
| Management average tenure | 14.7yrs |
| Board average tenure | 6.5yrs |
Recent management updates
Recent updates
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Apr 14
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Surges 27% Yet Its Low P/S Is No Reason For Excitement
Jan 28CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Oct 04There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise
May 03CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think
Apr 25CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky
Mar 26Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly
Sep 27Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?
Sep 16Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)
Aug 21These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively
Apr 14CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry
Mar 18If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns
Feb 01
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?
Jan 04CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet
Dec 09We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide
Nov 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | HK$7m | HK$3m | -HK$127m |
Compensation vs Market: Lance Richard's total compensation ($USD887.48K) is above average for companies of similar size in the Hong Kong market ($USD448.82K).
Compensation vs Earnings: Insufficient data to compare Lance Richard's compensation with company performance.
CEO
Lance Richard Yuen (58 yo)
less than a year
Tenure
HK$6,878,000
Compensation
Mr. Lee Yuen, also known as Lance Richard, is Executive Director, Vice President & Chief Executive Officer of CK Life Sciences Int'l. (Holdings) Inc. from September 20, 2024. Mr. Yuen joined the Group in S...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 23.1yrs | HK$125.00k | 0.023% HK$ 2.1m | |
| VP, CEO & Executive Director | less than a year | HK$6.88m | 0.024% HK$ 2.1m | |
| President & Executive Director | 22.9yrs | HK$3.08m | 0.041% HK$ 3.7m | |
| Senior VP | no data | HK$1.10m | 0.023% HK$ 2.1m | |
| VP, Chief Scientific Officer & Executive Director | 6.5yrs | HK$6.44m | no data | |
| Chief Financial Officer | no data | no data | no data | |
| Chief Operating Officer of Global Operations | no data | no data | no data | |
| General Manager of Human Resources & Administration | no data | no data | no data | |
| General Counsel | no data | no data | no data | |
| Vice President of Corporate Development | no data | no data | no data | |
| Chief Corporate Affairs Officer | no data | no data | no data | |
| Company Secretary | 23.3yrs | no data | no data |
14.7yrs
Average Tenure
59.5yo
Average Age
Experienced Management: 775's management team is seasoned and experienced (14.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 23.1yrs | HK$125.00k | 0.023% HK$ 2.1m | |
| VP, CEO & Executive Director | less than a year | HK$6.88m | 0.024% HK$ 2.1m | |
| President & Executive Director | no data | HK$3.08m | 0.041% HK$ 3.7m | |
| Senior VP | no data | HK$1.10m | 0.023% HK$ 2.1m | |
| VP, Chief Scientific Officer & Executive Director | 6.5yrs | HK$6.44m | no data | |
| Independent Non-Executive Director | 22.9yrs | HK$100.00k | 0.0021% HK$ 185.9k | |
| Co-Chairman of Vitaquest International LLC | no data | no data | no data | |
| Non-Executive Director | 23.1yrs | HK$75.00k | 0.011% HK$ 976.1k | |
| Deputy Chairman | less than a year | HK$15.26m | 0.023% HK$ 2.1m | |
| Independent Non-executive Director | 10.2yrs | HK$155.00k | no data | |
| Independent Non-Executive Director | 4.8yrs | HK$205.00k | no data | |
| Independent Non-Executive Director | 5.9yrs | HK$205.00k | no data |
6.5yrs
Average Tenure
70yo
Average Age
Experienced Board: 775's board of directors are considered experienced (6.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/03 16:49 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CK Life Sciences Int'l., (Holdings) Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jayaprabha Dhavale | Virtua Research Inc. |